Assignee
TAKEDA PHARMACEUTICALS USA INC
US·8 granted patents·11 pending applications·4 citations·filing 2011–2025
Top patents by PatentIndex Score
19 records- 0178US2025361232A1Substituted acetylenic pyrazolo[1,5-a]pyridine compounds as kinase inhibitorsTAKEDA PHARMACEUTICALS USA INC·Filed 2025·Application pending·0 cites
- 0277US12297432B2Oligonucleotides for the treatment of nucleotide repeat expansion disorders associated with MSH3 activityTAKEDA PHARMACEUTICALS USA INC·Filed 2022·Granted May 13, 2025·0 cites·9 claims
- 0372US9238029B2Multiple PPI dosage formTAKEDA PHARMACEUTICALS USA INC·Filed 2013·Granted Jan 19, 2016·2 cites·22 claims
- 0472US2025327073A1Oligonucleotides for the treatment of nucleotide repeat expansion disorders associated with msh3 activityTAKEDA PHARMACEUTICALS USA INC·Filed 2025·Application pending·0 cites
- 0567US8372872B2Methods for concomitant treatment of theophylline and febuxostatTAKEDA PHARMACEUTICALS USA INC·Filed 2011·Granted Feb 12, 2013·2 cites·1 claims
- 0667US2025207129A1Methods for the treatment of neurodegenerative disordersTAKEDA PHARMACEUTICALS USA INC·Filed 2023·Application pending·0 cites
- 0763US2024263179A1Methods for the treatment of nucleotide repeat expansion disorders associated with msh3 activityTAKEDA PHARMACEUTICALS USA INC·Filed 2022·Application pending·0 cites
- 0858US2025197856A1Methods for the treatment of nucleotide repeat expansion disorders associated with msh3 activityTAKEDA PHARMACEUTICALS USA INC·Filed 2023·Application pending·0 cites
- 0956US12485136B2Methods for the treatment of trinucleotide repeat expansion disorders associated with MLH3 activityTAKEDA PHARMACEUTICALS USA INC·Filed 2019·Granted Dec 2, 2025·0 cites·9 claims
- 1055US2014329868A1Methods for treating hypertensionTAKEDA PHARMACEUTICALS USA INC·Filed 2014·Application pending·0 cites
- 1149US9889152B2Multiple PPI dosage formTAKEDA PHARMACEUTICALS USA INC·Filed 2015·Granted Feb 13, 2018·0 cites·23 claims
- 1247US9255063B2Colchicine solid-state forms; methods of making; and methods of use thereofTAKEDA PHARMACEUTICALS USA INC·Filed 2012·Granted Feb 9, 2016·0 cites·16 claims
- 1346US9889125B2Methods for treating heartburn, gastric bleeding or hemorrhage in patients receiving clopidogrel therapyTAKEDA PHARMACEUTICALS USA INC·Filed 2015·Granted Feb 13, 2018·0 cites·10 claims
- 1441US2014357683A1Methods of treatment and compositions with xanthine oxidase inhibitorsTAKEDA PHARMACEUTICALS USA INC·Filed 2014·Application pending·0 cites
- 1540US2015164831A1Colchicine formulations; methods of making; and methods of use thereofTAKEDA PHARMACEUTICALS USA INC·Filed 2013·Application pending·0 cites
- 1638US2018311217A1Methods of treatment and compositions with xanthine oxidase inhibitorsTAKEDA PHARMACEUTICALS USA INC·Filed 2017·Application pending·0 cites
- 1737US9937157B2Modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitorsTAKEDA PHARMACEUTICALS USA INC·Filed 2016·Granted Apr 10, 2018·0 cites·20 claims
- 1834US2013158080A1Methods for treating hypertension in black patientsTAKEDA PHARMACEUTICALS USA INC·Filed 2012·Application pending·0 cites
- 1929US2013143886A1Methods for preserving and/or increasing renal function using xanthine oxidoreductase inhibitorsTAKEDA PHARMACEUTICALS USA INC·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when TAKEDA PHARMACEUTICALS USA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →